VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer

被引:35
|
作者
Urick, M. E. [1 ]
Giles, J. R. [1 ]
Johnson, P. A. [1 ]
机构
[1] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA
关键词
D O I
10.1016/j.ygyno.2008.05.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. We aimed to determine the expression of vascular endothelial growth factor (VEGF) and the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on the proliferation of cells isolated from ascites in the hen model of ovarian cancer. Methods. Ovarian tumor and normal ovary were collected from hens and ascites cells were isolated from hens with ovarian cancer. Quantitative real-time PCR was used to quantify mRNA expression. Immunohistochemical and/or Western blot analyses were used to localize protein expression in ovarian tumors, normal ovaries, and ascites cells. Cells were treated with a nonspecific. COX-I-specific, or COX-2-specific NSAID and proliferation was determined. Results. VEGF RNA was increased in ascites cells and there was a trend for a correlation between VEGF mRNA in ascites cells and ascites volume. VEGF protein was localized to theca cells of normal ovaries, in glandular areas of tumors, and to the cytoplasm of ascites cells. Aspirin and a COX-1-specific inhibitor decreased the proliferation of ascites cells, whereas a COX-2-specific inhibitor did not. Conclusions. VEGF may play a role in ovarian cancer progression in the hen and the proliferation of ascites cells can be decreased by targeting the COX-I but not COX-2 pathway. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:418 / 424
页数:7
相关论文
共 50 条
  • [21] EFFECT OF EGF ON VEGF EXPRESSION IN COLON CANCER CELL LINE
    Amodeo, V
    Insalaco, L.
    Terrasi, M.
    D'Andrea, A.
    Fanale, D.
    La Paglia, L.
    Corsini, L. R.
    Bazan, V
    Russo, A.
    CYTOMETRY PART A, 2010, 77A (02) : 192 - 193
  • [22] Global Gene Expression Analysis in Ovarian Cancer of the Hen.
    Trevino, Lindsey S.
    Wang, Wei
    Urick, Mary Ellen
    Johnson, Patricia A.
    BIOLOGY OF REPRODUCTION, 2009, : 169 - 170
  • [23] Elevated VEGF concentrations in ascites and serum predict adverse prognosis in ovarian cancer
    Liang, Bin
    Guo, Zhengdong
    Li, Yunhui
    Liu, Chuan
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (04): : 309 - 314
  • [24] VEGF EXPRESSION: A USEFUL TOOL IN PREDICTION OF REFRACTORINESS TO PLATINUM-BASED CHEMOTHERAPY AND ASCITES FORMATION IN EPITHELIAL OVARIAN CANCER
    Masoumi-Moghaddam, S.
    Amini, A.
    Wei, A.
    Robertson, G.
    Morris, D. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1436 - 1436
  • [25] Gemcitabine suppresses malignant ascites of human pancreatic ductal cancer ; Correlation with VEGF expression in ascites
    Kuwahara, K
    Sasaki, T
    Morinaka, K
    Kariya, K
    Kuwada, Y
    Yamasaki, S
    Murakami, M
    Miyata, H
    Iiboshi, T
    Serikawa, M
    Chayama, K
    GASTROENTEROLOGY, 2003, 124 (04) : A425 - A425
  • [26] Single cell analysis of ascites macrophages in ovarian cancer
    He, Huanhuan Mahsa
    Yu, Feigiao Brian
    Quake, Stephen R.
    Dorigo, Oliver
    CANCER RESEARCH, 2015, 75
  • [27] Ovarian Cancer Cell Survival and Proliferation Is Mediated by the Warburg Effect.
    Ladley, Sara Elizabeth
    Hales, Dale Buck
    BIOLOGY OF REPRODUCTION, 2011, 85
  • [28] Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
    HuaPing Li
    HuaLi Li
    HongJie Qu
    MingZhu Zhao
    Bo Yuan
    MingHua Cao
    JinQuan Cui
    Cancer Cell International, 15
  • [29] Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
    Li, HuaPing
    Li, HuaLi
    Qu, HongJie
    Zhao, MingZhu
    Yuan, Bo
    Cao, MingHua
    Cui, JinQuan
    CANCER CELL INTERNATIONAL, 2015, 15
  • [30] High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation
    Xiu, Lin
    Zhao, Yuxi
    Li, Ning
    Zeng, Jia
    Liu, Jing
    Fu, Yongliang
    Gao, Qiao
    Wu, Lingying
    FRONTIERS IN ONCOLOGY, 2022, 12